Return on Equity (ROE)

Return on equity measures the returns generated by the equity capital. ROE is defined as:

ROE = Net Income / Shareholder's equity

A lot of practical considerations have to be taken while calculating the ROE. Net Income is typically for trailing twelve months TTM. Shareholder's equity is sometimes taken as average of shareholder's equity at the beginning of a period and at the end of the period. If there are new shares issued during the period then weighted average of the number of shares for the period may be taken.Sometimes preferred dividends, paid to preferred stock holders, are subtracted from the net income to find the income attributable to common stock. Correspondingly equity also is considered as only the common stock.

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)34.1811.85 (53.07%)
SEVEN STARS CLD (SSC)2.210.47 (27.01%)
Aralez Pharma (ARLZ)1.80.28 (18.42%)
Quad Graphics (QUAD)22.582.81 (14.21%)
Aegean Marine Petroleum (ANW)4.650.55 (13.41%)
Oramed Pharma (ORMP)10.711.21 (12.74%)
Mesabi (MSB)23.452.55 (12.2%)
Top gainers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 23, 2017
CompanyPriceChange (%)
Versartis (VSAR)2.67518.93 (87.64%)
Revolution Lighting (RVLT)6.261.32 (17.41%)
Intercept Pharma (ICPT)61.5912.11 (16.43%)
Compass Minerals (CMP)60.19.4 (13.53%)
Exelixis (EXEL)24.473.54 (12.64%)
Epizyme (EPZM)16.951.75 (9.36%)
Matson (MATX)26.352.32 (8.09%)
Top losers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 23, 2017